UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Raises Stake in Oscar Health, Inc. (NYSE:OSCR)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 29.2% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 353,491 shares of the company's stock after buying an additional 79,801 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.15% of Oscar Health worth $7,498,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in OSCR. Point72 Hong Kong Ltd purchased a new position in Oscar Health in the 2nd quarter valued at about $78,000. Quest Partners LLC acquired a new position in shares of Oscar Health in the 2nd quarter valued at $93,000. KBC Group NV boosted its stake in Oscar Health by 41.2% during the third quarter. KBC Group NV now owns 4,552 shares of the company's stock worth $97,000 after buying an additional 1,328 shares during the period. Amalgamated Bank boosted its position in shares of Oscar Health by 27.7% during the 2nd quarter. Amalgamated Bank now owns 6,727 shares of the company's stock worth $106,000 after purchasing an additional 1,458 shares during the period. Finally, Optimum Investment Advisors purchased a new position in shares of Oscar Health during the third quarter worth $142,000. Hedge funds and other institutional investors own 75.70% of the company's stock.

Oscar Health Stock Down 9.2 %

NYSE:OSCR traded down $1.53 during midday trading on Tuesday, hitting $15.02. 4,940,244 shares of the company were exchanged, compared to its average volume of 3,452,520. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a fifty-two week low of $7.50 and a fifty-two week high of $23.79. The company has a market capitalization of $3.71 billion, a PE ratio of -259.17 and a beta of 1.64. The company has a fifty day simple moving average of $16.80 and a 200 day simple moving average of $17.77.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share for the quarter, missing the consensus estimate of ($0.20) by ($0.02). The firm had revenue of $2.42 billion during the quarter, compared to analysts' expectations of $2.33 billion. Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The firm's revenue for the quarter was up 68.3% on a year-over-year basis. During the same period in the previous year, the firm posted ($0.29) earnings per share. As a group, equities analysts anticipate that Oscar Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts recently weighed in on the stock. Bank of America cut shares of Oscar Health from a "neutral" rating to an "underperform" rating and dropped their price objective for the company from $21.00 to $13.50 in a report on Wednesday, November 6th. Piper Sandler reaffirmed an "overweight" rating and issued a $28.00 target price on shares of Oscar Health in a report on Tuesday, September 10th. Jefferies Financial Group initiated coverage on shares of Oscar Health in a research note on Tuesday. They issued an "underperform" rating and a $12.00 price target for the company. Finally, UBS Group started coverage on shares of Oscar Health in a research report on Monday, October 7th. They issued a "neutral" rating and a $23.00 price objective on the stock. Two analysts have rated the stock with a sell rating, two have given a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $21.56.

Insider Activity

In other Oscar Health news, insider Mario Schlosser sold 6,516 shares of the business's stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total value of $117,809.28. Following the transaction, the insider now directly owns 81,962 shares of the company's stock, valued at approximately $1,481,872.96. The trade was a 7.36 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Thrive Partners Vii Growth Gp, bought 420,819 shares of Oscar Health stock in a transaction dated Tuesday, November 12th. The stock was purchased at an average price of $13.68 per share, with a total value of $5,756,803.92. Following the purchase, the director now directly owns 5,452,081 shares in the company, valued at approximately $74,584,468.08. This trade represents a 8.36 % increase in their position. The disclosure for this purchase can be found here. Over the last ninety days, insiders bought 1,055,478 shares of company stock valued at $14,432,852 and sold 103,610 shares valued at $1,847,519. Corporate insiders own 25.11% of the company's stock.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.